Blood Reviews
Volume 22, Issue 1 , Pages 1-15 , January 2008

Cold antibody autoimmune hemolytic anemias

References 

  1. Petz LD, Garratty G. Classification and Clinical Characteristics of Autoimmune Hemolytic Anemias. In:  Petz LD,  Garratty G editor. Immune Hemolytic Anemias. second ed.. Philadelphia: Churchill Livingstone; 2004;p. 61–131
  2. Petz LD, Garratty G. Acquired Immune Hemolytic Anemias. first ed.. New York: Churchill; 1980;
  3. Dacie JV, Worlledge SM. Auto-immune hemolytic anemias. In:  Brown EB,  Moore CV editor. Progr.Hematol. sixth ed.. New York: Grune and Stratton; 1969;p. 82–120
  4. Van Loghem JJ, Van der Hart M, Dorfmeier H. Serological studies in acquired hemolytic anemia. Proceedings of the Sixth International Congress of the International Society of Hematology. New York: spring; 1958;
  5. Dausset J, Colombani J. The serology and the prognosis of 128 cases of autoimmune hemolytic anemia. Blood. 1959;14:1280
  6. Worlledge S. Auto-immunity and blood diseases. Practitioner. 1967;199:171–179
  7. Dacie JV. Auto-immune haemolytic anaemia (AIHA): cold-antibody syndromes. I: idiopathic types: clinical presentation and haematological and serological findings. The Haemolytic Anaemias. third ed.. The Auto-Immune Haemolytic Anaemias. New York: Churchill Livingstone; 1992;p. 210–39
  8. Habibi B, Homberg JC, Schaison G, Salmon C. Autoimmune hemolytic anemia in children. A review of 80 cases. Am J Med. 1974;56:61–69
  9. Zupanska B, Lawkowicz W, Gorska B, et al. Autoimmune haemolytic anaemia in children. Br J Haematol. 1976;34:511–520
  10. McNicholl FP. Clinical syndromes associated with cold agglutinins. Transfus Sci. 2000;22:125–133
  11. Nydegger UE, Kazatchkine MD, Miescher PA. Immunopathologic and clinical features of hemolytic anemia due to cold agglutinins. Seminars Hematol. 1991;28:66–77
  12. Schubothe H. The cold hemagglutinin disease. Semin Hematol. 1966;3:27–47
  13. Crisp D, Pruzanski W. B-cell neoplasms with homogeneous cold-reacting antibodies (cold agglutinins). Am J Med. 1982;72:915–922
  14. Ferriman DG, Dacie JV, Keele KD, Fullerton JM. The association of Raynaud’s phenomena, chronic haemolytic anaemia, and the formation of cold antibodies. Quart J Med. 1951;20:275
  15. Pirofsky B. Autoimmunization and the Autoimmune Hemolytic Anemias. Baltimore: Williams & Wilkins; 1969;
  16. Lauchli S, Widmer L, Lautenschlager S. Cold agglutinin disease–the importance of cutaneous signs. Dermatology. 2001;202:356–358
  17. Mitchell AB, Pergrum GD, Gill AM. Cold agglutinin disease with Raynaud’s phenomenon. Proc R Soc Med. 1974;67:113–115
  18. Poldre P, Pruzanski W, Chiu HM, Dotten DA. Fulminant gangrene in transient cold agglutinemia associated with Escherichia coli infection. Can Med Assoc J. 1985;132:261–263
  19. Stone MS, Piette WW, Davey WP. Cutaneous necrosis at sites of transfusion: cold agglutinin disease. J Am Acad Dermatol. 1988;19(2 Pt 1):356–357
  20. Zouboulis CC, Gollnick H, Orfanos CE. Essential thrombocythemia and idiopathic cold agglutinin disease: two additional disorders associated with intravascular coagulation necrosis of the skin. J Am Acad Dermatol. 1992;27(2 Pt 1):277
  21. Barth JH. Infectious mononucleosis (glandular fever) complicated by cold agglutinins, cold urticaria and leg ulceration. Acta Derm Venereol. 1981;61:451–452
  22. Packman CH. Cryopathic hemolytic syndromes. In:  Beutler E,  Lichtman MA,  Coller BS,  Kipps TJ editor. Williams Hematology. sixth ed.. New York: McGraw-Hill; 1995;p. 649–655
  23. DeLange JA, Eernisse GJ, Veltkamp JJ. Cold agglutinins and the Coulter Counter Model S. Am J Clin Pathol. 1972;58:599–600
  24. Lawrence C, Zozicky O. Spurious red-cell values with the Coulter Counter. N Engl J Med. 1983;309:925–926
  25. Petrucci JV, Dunne PA, Chapman CC. Spurious erythrocyte indices as measured by the model S Coulter counter due to cold agglutinins. Am J Clin Pathol. 1971;56:500–502
  26. Hattersley PG, Gerard PW, Caggiano V, Nash DR. Erroneous values on the Model S Coulter Counter due to high titer cold autoagglutinins. Am J Clin Pathol. 1971;55:442–446
  27. Roelcke D. Cold agglutination. Transfus Med Rev. 1989;3:140–166
  28. Leddy JP, Swisher SN. Acquired Immune Hemolytic Disorders (Including Drug-Induced Immune Hemolytic Anemia). In:  Samter M editors. Immunologic Diseases. 3 ed.. Boston: Little Brown & Co.; 1978;p. 1187
  29. Schreiber AD, Herskovitz BS, Goldwein M. Low-titer cold-hemagglutinin disease. Mechanism of hemolysis and response to corticosteroids. N Engl J Med. 1977;296:1490–1494
  30. Rosse WF. Correlation of in vivo and in vitro measurements of hemolysis in hemolytic anemia due to immune reactions. Prog Hematol. 1973;8:51–75
  31. Fudenberg HH, Kunkel HG. Physical properties of the red cell agglutinins in acquired hemolytic anaemia. J Exp Med. 1957;1:689
  32. Schwartz T, Jager BV. Cryoglobulinemia and Raynaud’s syndrome in a case of chronic lymphocytic leukemia. Cancer. 1949;2:319
  33. Dacie JV. Auto-immune haemolytic anaemias (AIHA): treatment. third ed.. The Haemolytic Anaemias; The Auto-Immune Haemolytic Anaemias. New York: Churchill Livingstone; 1992;p. 452–520
  34. Pisciotta AV. Cold hemagglutination in acute and chronic hemolytic syndromes. Blood. 1955;10:295
  35. Firkin BG, Blackwell JB, Johnston GAW. Essential cryoglobulinaemia and acquired haemolytic anaemia due to cold agglutinins. Australian Ann Med. 1959;8:151
  36. Nanan R, Scheurlen W, Gerlich M, Huppertz HI. Severe low-titer cold-hemagglutinin disease responsive to steroid pulse therapy. Ann Hematol. 1995;71:101–102
  37. Lahav M, Rosenberg I, Wysenbeek AJ. Steroid-responsive idiopathic cold agglutinin disease: a case report. Acta Haematol. 1989;81:166–168
  38. Worlledge S. Immune Haemolytic Anaemias. In:  Hardisty RM,  Weatherall DJ editor. Blood and its Disorders. Oxford: Blackwell; 1982;p. 479–513
  39. Worlledge SM, Brain MC, Cooper AC, Hobbs JR, Dacie JV. Immmunosuppressive drugs in the treatment of autoimmune haemolytic anaemia. Proc R Soc Med. 1968;61:1312–1315
  40. Hippe E, Jensen KB, Olesen H, Lind K, Thomsen PE. Chlorambucil treatment of patients with cold agglutinin syndrome. Blood. 1970;35:68–72
  41. Jacobs A. Cold agglutinin hemolysis responding to fludarabine therapy. Am J Hematol. 1996;53:279–280
  42. Petz LD, Garratty G. Drug-Induced Immune Hemolytic Anemia. In:  Petz LD,  Garratty G editor. Immune Hemolytic Anemias. second ed.. Philadelphia: Churchill Livingstone; 2004;p. 261–317
  43. Pescovitz MD. Rituximab, and anti-CD20 monoclonal antibody: history and mechanism of action. American Journal of Transplantation. 2006;6:859–866
  44. Lee E, Zamkoff KW, Gentile TC, Zimrin A. Rituxan in the treatment of auto-immune hemolytic anemia (AIHA). Blood. 2000;96:596a–597a
  45. Berentsen S, Tjonnfjord GE, Gjertsen BT, Hammerstron J, Langholm R, Sorbo JH. Rituxan (Rituximab) therapy for chronic cold agglutinin disease. Blood. 2000;96:524a
  46. Berentsen S, Tjonnfjord GE, Brudevold R, et al. Favourable response to therapy with the anti-CD20 monoclonal antibody rituximab in primary chronic cold agglutinin disease. Br J Haematol. 2001;115:79–83
  47. Pulik M, Genet P, Lionnet F, Touahri T. Treatment of primary chronic cold agglutinin disease with rituximab: maintenance therapy may improve the results. Br J Haematol. 2002;117:998–999
  48. Berentsen S, Ulvesstad E, Gjertsen BT, et al. Rituximab for primary chronic cold agglutinin disease: a prospective study of 37 courses of therapy in 27 patients. Blood. 2004;103:2925–2928
  49. Schollkopf C, Kjeldsen L, Bjerrum OW, et al. Rituximab in chronic cold agglutinin disease: a prospective study of 20 patients. Leukemia & Lymphoma. 2006;47:253–260
  50. Layios N, Van Den NE, Jost E, Deneys V, Scheiff JM, Ferrant A. Remission of severe cold agglutinin disease after Rituximab therapy. Leukemia. 2001;15:187–188
  51. Mori A, Tamaru J, Sumi H, Kondo H. Beneficial effects of rituximab on primary cold agglutinin disease refractory to conventional therapy. Eur J Haematol. 2002;68:243–246
  52. Engelhardt M, Jakob A, Ruter B, Trepel M, Hirsch F, Lubbert M. Severe cold hemagglutinin disease (CHD) successfully treated with rituximab. Blood. 2002;100:1922–1923
  53. Cohen Y, Polliack A, Zelig O, Goldfarb A. Monotherapy with rituximab induces rapid remission of recurrent cold agglutinin-mediated hemolytic anemia in a patient with indolent lymphoplasmacytic lymphoma. Leukemia & Lymphoma. 2007;42:1405–1408
  54. Kotani T, Takeuchi T, Kawasaki Y, et al. Successful treatment of cold agglutinin disese with anti-CD20 antibody (rituximab) in a patient with systemic lupus erythematosus. Lupus. 2007;15:683–685
  55. McLeod BC, Strauss RG, Ciavarella D, et al. Management of hematological disorders and cancer. J Clin Apheresis. 1993;8:211–230
  56. McCurdy PR, Rath CE. Splenectomy in hemolytic anemia: results predicted by body scanning after injection of Cr51-tagged red cells. New Engl J Med. 1958;259:459
  57. Bell CA, Zwicker H, Sacks HJ. Autoimmune hemolytic anemia: routine serologic evaluation in a general hospital population. Am J Clin Pathol. 1973;60:903–911
  58. Dacie JV. The Haemolytic Anaemias. second ed.. Part II. Auto-Immune Haemolytic Anaemias. London: J. & A Churchill Ltd.; 1962;
  59. Evans RS, Bingham M, Turner E. Autoimmune hemolytic disease: Observations of serologic reactions and disease activity. Ann NY Acad Sci. 1965;124:422
  60. Ratko TA. Technology Assessment: Intravenous Immunoglobulin Preparations. Oak Brook, Illinois: University HealthSystem Consortium; 1999;
  61. Besa EC. Rapid transient reversal of anemia and long-term effects of maintenance intravenous immunoglobulin for autoimmune hemolytic anemia in patients with lymphoproliferative disorders. Am J Med. 1988;84:691–698
  62. Seldon M, Isbister JP, Raik E, Biggs JC. A fatal case of cold autoimmune hemolytic anemia. Am J Clin Pathol. 1980;73:716–717
  63. Rousey SR, Smith RE. A fatal case of low titer anti-PR cold agglutinin disease. Am J Hematol. 1990;35:286–287
  64. Howard CP, Mills ES. Paroxysmal hemoglobinuria. Amer J Med Sci. 1938;196:792
  65. Becker RM. Paroxysmal cold hemoglobinurias. Arch Intern Med. 1948;81:630
  66. Buchanan GR, Boxer LA, Nathan DG. The acute and transient nature of idiopathic immune hemolytic anemia in childhood. J Pediatr. 1976;88:780–783
  67. Johnsen HE, Brostrphom K, Madsen M. Paroxysmal cold haemoglobinuria in children: 3 cases encountered within a period of 7 months. Scand J Haematol. 1978;20:413–416
  68. Bird GW, Wingham J, Martin AJ, et al. Idiopathic non-syphilitic paroxysmal cold haemoglobinuria in children. J Clin Pathol. 1976;29:215–218
  69. Sokol RJ, Hewitt S, Stamps BK, Hitchen PA. Autoimmune haemolysis in childhood and adolescence. Acta Haematol. 1984;72:245–257
  70. Gottsche B, Salama A, Mueller-Eckhardt C. Donath-Landsteiner autoimmune hemolytic anemia in children. A study of 22 cases. Vox Sang. 1990;58:281–286
  71. Wynn RF, Stevens RF, Bolton-Maggs PH, Schwe K, Will AM. Paroxysmal cold haemoglobinuria of childhood: a review of the management and unusual presenting features of six cases. Clin Lab Haematol. 1998;20:373–375
  72. Lambert T, Noblins M, Tchernia G. Biphasic hemolysin hemolytic anemia in children. Am J Hematol. 1993;43:77
  73. Nordhagen R, Stensvold K, Winsnes A, Skyberg D, Storen A. Paroxysmal cold haemoglobinuria. The most frequent acute autoimmune haemolytic anaemia in children?. Acta Paediatr Scand. 1984;73:258–262
  74. Heddle NM. Acute paroxysmal cold hemoglobinuria. Transfus Med Rev. 1989;3:219–229
  75. Dacie JV. Auto-immune haemolytic anaemia (AIHA): cold-antibody syndromes V: paroxysmal cold haemoglobinuria (PCH). The Haemolytic Anaemias. third ed.. The Auto-Immune Haemolytic Anaemias. New York: Churchill Livingstone; 1992;p. 329–362
  76. Sokol RJ, Hewitt S, Stamps BK. Autoimmune haemolysis associated with Donath-Landsteiner antibodies. Acta Haematol. 1982;68:268–277
  77. Sokol RJ, Booker DJ, Stamps R. Erythropoiesis: Paroxysmal cold haemoglobinuria: A clinico-pathological study of patients with a positive Donath-Landsteiner test. Hematol. 1999;4:137–164
  78. Wolach B, Heddle N, Barr RD, Zipursky A, Pai KR, Blajchman MA. Transient Donath-Landsteiner haemolytic anaemia. Br J Haematol. 1981;48:425–434
  79. Bunch C, Schwartz FC, Bird GW. Paroxysmal cold haemoglobinuria following measles immunization. Arch Dis Child. 1972;47:299–300
  80. O’Neill BJ, Marshall WC. Paroxysmal cold haemoglobinuria and measles. Arch Dis Child. 1967;42:183–186
  81. Sharpe JS, Booker DJ, Stamps R, Sokol RJ. Parvovirus B19 infection and paroxysmal cold haemoglobinuria. Transfus Med. 1996;6(Suppl 2):24
  82. Lindgren S, Zimmerman S, Gibbs F, Garratty G. An unusual Donath-Landsteiner antibody detectable at 37 degrees C by the antiglobulin test. Transf. 1985;25:142–144
  83. Garratty G. Erythrophagocytosis on the peripheral blood smear and paroxysmal cold hemoglobinuria. Transf. 2001;41:1073–1074
  84. Friedman HD, Dracker RA. Intravascular erythrophagocytosis. JAMA. 1991;265:1082
  85. Gelfand EW, Abramson N, Segel GB, Nathan DG. Buffy-coat observations and red-cell antibodies in acquired hemolytic anemia. N Engl J Med. 1971;284:1250–1252
  86. Hernandez JA, Steane SM. Erythrophagocytosis by segmented neutrophils in paroxysmal cold hemoglobinuria. Am J Clin Pathol. 1984;81:787–789
  87. Worlledge S. Immune Haemolytic Anemias. In:  Hardisty RM,  Weatherall DJ editor. Blood and Its Disorders. Oxford: Blackwell; 1974;p. 714
  88. Sokol RJ, Booker DJ, Stamps R. Erythrocyte autoantibodies, autoimmune haemolysis, and carcinoma. J Clin Pathol. 1994;47:340–343
  89. Sokol RJ, Hewitt S. Autoimmune hemolysis: a critical review. Crit Rev Oncol Hematol. 1985;4:125–154
  90. Sokol RJ, Hewitt S, Booker DJ. Erythrocyte autoantibodies, autoimmune haemolysis, and myelodysplastic syndromes. J Clin Pathol. 1989;42:1088–1091
  91. Hsu HC, Lin CK, Chau WK, Hu HY, Liu SM. Combined cold- and warm-antibody autoimmune hemolytic anemia–review of the literature and a case report. Gaoxiong Yi Xue Ke Xue Za Zhi. 1989;5:350–356
  92. Sheth SS, Karande SC, Nadkarni VB, Lahiri K, Jain MK, Shah MD. Autoimmune hemolytic anemia–mixed type. Indian Pediatr. 1991;28:303–304
  93. Zupanska B, Sokol RJ, Booker DJ, Stamps R. Erythrocyte autoantibodies, the monocyte monolayer assay and in vivo haemolysis. Br J Haematol. 1993;84:144–150
  94. Sokol RJ, Hewitt S, Stamps BK. Autoimmune hemolysis: mixed warm and cold antibody type. Acta Haematologica. 1983;69:266–274
  95. Shulman IA, Branch DR, Nelson JM, Thompson JC, Saxena S, Petz LD. Autoimmune hemolytic anemia with both cold and warm autoantibodies. JAMA. 1985;253:1746–1748
  96. Koduri PR, Singa P, Nikolinakos P. Autoimmune hemolytic anemia in patients infected with human immunodeficiency virus-1. Am J Hematol. 2002;70:174–176
  97. Nusbaum NJ, Khosla S. Autoimmune hemolytic anemia with both cold and warm autoantibodies. JAMA. 1985;254:1175–1176
  98. Barry KG, Crosby WH. Auto-immune hemolytic anemia arrested by removal of an ovarian teratoma: review of the literature and report of a case. Ann Intern Med. 1957;47:1002–1007
  99. Dawson MA, Talbert W, Yarbro JW. Hemolytic anemia associated with an ovarian tumor. Am J Med. 1971;50:552–556
  100. de Bruyere M, Sokal G, Devoitille JM, Fauchet-Dutrieux MC, De SV. Autoimmune haemolytic anaemia and ovarian tumour. Br J Haematol. 1971;20:83–94
  101. Payne D, Muss HB, Homesley HD, Jobson VW, Baird FG. Autoimmune hemolytic anemia and ovarian dermoid cysts: case report and review of the literature. Cancer. 1981;48:721–724
  102. Duhrsen U, Augener W, Zwingers T, Brittinger G. Spectrum and frequency of autoimmune derangements in lymphoproliferative disorders: analysis of 637 cases and comparison with myeloproliferative diseases. Br J Haematol. 1987;67:235–239
  103. Miller DG. The association of immune disease and malignant lymphoma. Ann Intern Med. 1967;66:507–521
  104. Engelfriet CP, Overbeeke MA, dem Borne AE. Autoimmune hemolytic anemia. Semin Hematol. 1992;29:3–12
  105. Diehl LF, Ketchum LH. Autoimmune disease and chronic lymphocytic leukemia: autoimmune hemolytic anemia, pure red cell aplasia, and autoimmune thrombocytopenia. Semin Oncol. 1998;25:80–97
  106. Mauro FR, Foa R, Cerretti R, et al. Autoimmune hemolytic anemia in chronic lymphocytic leukemia: clinical, therapeutic, and prognostic features. Blood. 2000;95:2786–2792
  107. Hansen MM. Chronic lymphocytic leukaemia. Clinical studies based on 189 cases followed for a long time. Scand J Haematol Suppl. 1973;18:3–286
  108. Bartal A, Bentwich Z, Manny N, Izak G. Ethnical and clinical aspects of chronic lymphocytic leukemia in Israel: a survey on 288 patients. Acta Haematol. 1978;60:161–171
  109. Seaman AJ, Koler RD, Pirofsky B, et al. Incidence and treatment of acquired hemolytic anemia complicating chronic lymphocytic leukemia. Proceedings of the Sixth International Congress of the International Society of Hematology. 1956;857
  110. Robertson TI. Complications and causes of death in B cell chronic lymphocytic leukaemia: a long term study of 105 patients. Aust N Z J Med. 1990;20:44–50
  111. De Rossi G, Granati L, Girelli G, et al. Incidence and prognostic significance of autoantibodies against erythrocytes and platelets in chronic lymphocytic leukemia (CLL). Nouv Rev Fr Hematol. 1988;30:403–406
  112. Greally JF, Whelan CA, O’Connell L, O’Gorman D. Cold agglutinins in a case of chronic lymphatic leukaemia. A study of the lymphocyte surface. Acta Haematol. 1977;57:206–210
  113. Schwartz TB, Jager BV. Cryoglobulinemia and Raynaud’s syndrome in a case of chronic lymphocytic leukemia. Cancer. 1949;2:319–328
  114. Dacie JV. The Haemolytic Anaemias. third ed.. Secondary or Symptomatic Haemolytic Anaemias. New York: Churchill Livingstone; 1995;
  115. Ruzickova S, Pruss A, Odendahl M, et al. Chronic lymphocytic leukemia preceded by cold agglutinin disease: intraclonal immunoglobulin light-chain diversity in V(H)4-34 expressing single leukemic B cells. Blood. 2002;100(9):3419–3422
  116. Eisner E, Ley AB, Mayer K. Coombs’-positive hemolytic anemia in Hodgkin’s disease. Ann Intern Med. 1967;66:258–273
  117. Levine AM, Thornton P, Forman SJ, et al. Positive Coombs test in Hodgkin’s disease: significance and implications. Blood. 1980;55:607–611
  118. Economopoulos T, Stathakis N, Constantinidou M, Papageorgiou E, Anastassiou C, Raptis S. Cold agglutinin disease in non-Hodgkin’s lymphoma. Eur J Haematol. 1995;55:69–71
  119. Mainwaring CJ, Walewska R, Snowden J, et al. Fatal cold anti-i autoimmune haemolytic anaemia complicating hairy cell leukaemia. Br J Haematol. 2000;109:641–643
  120. Costea N, Yakulis VJ, Heller P. The mechanisms of induction of cold agglutinins by M pneumoniae. Blood. 1968;34:829;Ref Type: Abstract
  121. Bassan R, Pronesti M, Buzzetti M, et al. Autoimmunity and B-cell dysfunction in chronic proliferative disorders of large granular lymphocytes/natural killer cells. Cancer. 1989;63:90–95
  122. Liaw YS, Yang PC, Su IJ, Kuo SH, Wang CH, Luh KT. Mucosa-associated lymphoid tissue lymphoma of the lung with cold-reacting autoantibody-mediated hemolytic anemia. CHEST. 1994;105:288–290
  123. Pascali E. Monoclonal gammopathy and cold agglutinin disease in non-Hodgkin’s lymphoma. Eur J Haematol. 1996;56:114–115
  124. Bar BM, Reijnders FJ, Keuning JJ, Bal H, van Beek M. Primary malignant lymphoma of the uterine cervix associated with cold-reacting autoantibody-mediated hemolytic anemia. Acta Haematol. 1986;75:232–235
  125. Ritzmann SE, Levin WC. Cold agglutinin disease: A type of primary macroglobulinemia: a new concept. Tex Rep Biol Med. 1962;20:236
  126. Johnson SA, Oscier DG, Leblond V. Waldenstrom’s macroglobulinaemia. Blood Reviews. 2002;16:175–184
  127. Pruzanski W, Shumak KH. Biologic activity of cold-reacting autoantibodies (first of two parts). N Engl J Med. 1977;297:538–542
  128. Pruzanski W, Shumak KH. Biologic activity of cold-reacting autoantibodies (second of two parts). N Engl J Med. 1977;297:583–589
  129. Wortman J, Rosse W, Logue G. Cold agglutinin autoimmune hemolytic anemia in nonhematologic malignancies. Am J Hematol. 1979;6:275–283
  130. Lands R, Foust J. Renal cell carcinoma and autoimmune hemolytic anemia. South Med J. 1996;89:444–445
  131. Cao L, Kaiser P, Gustin D, Hoffman R, Feldman L. Cold agglutinin disease in a patient with uterine sarcoma. Am J Med Sci. 2000;320:352–354
  132. Banov CH. Paroxysmal cold hemoglobinuria: Apparent remission after splenectomy. JAMA. 1960;174:1974
  133. Patel M, Durao H, Govender Y. Paroxysmal cold haemoglobinuria coexisting with cold agglutinins in a patient with syphilis resulting in peripheral gangrene: a case report. East Afr Med J. 1993;70:526–527
  134. Carswell J, Eloff P, Edkins P, Willmore A. Paroxysmal cold haemoglobinuria. A case report. S Afr Med J. 1979;55:891–892
  135. Nelson MG, Nicholl B. Paroxysmal cold haemoglobinuria. Irish J Med Sci. 1960;6th series:49–57
  136. Wood JK. Paroxysmal cold haemoglobinuria in Jamaica. A case report. West Indian Med J. 1968;17:175–179
  137. Shah AA, Desai AB. Paroxysmal cold hemoglobinuria (case report). Indian Pediatr. 1977;14:219–221
  138. Kumar ND, Sethi S, Pandhi RK. Paroxysmal cold haemoglobinuria in syphilis patients. Genitourin Med. 1993;69:76
  139. Sharara AI, Hillsley RE, Wax TD, Rosse WF. Paroxysmal cold hemoglobinuria associated with non-Hodgkin’s lymphoma. South Med J. 1994;87:397–399
  140. Sivakumaran M, Murphy PT, Booker DJ, Wood JK, Stamps R, Sokol RJ. Paroxysmal cold haemoglobinuria caused by non-Hodgkin’s lymphoma. Br J Haematol. 1999;105:278–279
  141. Lippman SM, Winn L, Grumet FC, Levitt LJ. Evans’ syndrome as a presenting manifestation of atypical paroxysmal cold hemoglobinuria. Am J Med. 1987;82:1065–1072

PII: S0268-960X(07)00051-3

doi: 10.1016/j.blre.2007.08.002

Blood Reviews
Volume 22, Issue 1 , Pages 1-15 , January 2008

Article Tools